Adults with moderate to severe rheumatoid arthritis (RA)
ORENCIA has been shown to reduce signs and symptoms in adults with moderate to severe
(RA), including those who have not been helped enough by other medicines for RA.
ORENCIA may prevent further damage to bones and joints, and may help with the ability
to perform daily activities.
Children with moderate to severe juvenile idiopathic arthritis (JIA)
ORENCIA is indicated for reducing the signs and symptoms in pediatric patients 6
years of age or older with moderately to severely active polyarticular JIA. ORENCIA
may be used by itself or in combination with methotrexate.
How ORENCIA can help improve your health-related quality of life.
Select the link below to watch a special slidehow about how ORENCIA might be able
to make an impact on your health related quality of life. Learn about the specific
areas scientists use to study the impact moderate to severe RA can have on patients
beyond just the symptoms, such as:
|
•
|
Physical limitations in daily activities
|
|
•
|
Vitality or social function
|
|
•
|
Mental and general health
|

How satisfied are you with your ability to do everyday tasks?
After watching the health-quality of life slideshow, take our brief Satisfaction
RAter assessment, a great tool that lets you assess how well you're living with
your RA on a daily basis. It includes a health survey that covers 8 key areas RA
may be affecting you physically and emotionally.

Open up to your doctor about RA
Once you have a better understanding of how RA affects your daily life, you can
use our Doctor Discussion Guide to help prepare for your next rheumatologist visit.
It's a tool that can help you have a more meaningful and productive conversation
with your doctor — complete with questions to ask and information you need
to share. Browse through this section to find helpful tips, advice and answers to
many of your questions.

The more common side effects with ORENCIA are headache, upper respiratory tract
infection, sore throat, and nausea.
Next section: ORENCIA
in clinical trials
Previous section:
How ORENCIA is different
|